$NTR

Tuesday’s analyst upgrades and downgrades

National Bank Financial downgraded Nutrien Ltd. (NTR) to 'sector perform' due to valuation concerns, though its target price rose to $77. Cenovus Energy (CVE) was reaffirmed as 'outperform' with a $60 target. TD Cowen finds H&R REIT's (HR.UN) takeover bid 'underwhelming', lowering its target to $11. High Tide (HITI) was seen as having 'meaningful incremental value'.

Original reporting
Published Aug 25, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 25, 2026, 1:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Tuesday’s analyst upgrades and downgrades — source image
Decision brief

The 30-second read

$NTRBearishLow
01

Why it matters

Analyst upgrades/downgrades can prompt short‑term price moves, especially for Nutrien and Cenovus, while High Tide's commentary may spark limited interest.

02

Market read

Rating changes affect commodity‑linked stocks, offering modest trading ideas.

03

What to watch

Potential catalyst from Nutrien's upcoming investor day and Cenovus's upcoming production data could shift sentiment.

Relevance 5/10Novelty 5/10Timing: pre‑market today

Background

The article aggregates analyst rating actions and target revisions for several Canadian and US listed companies.

Company-level read

Ticker impact

$NTRBearishMedium confidence
Context

National Bank Financial downgraded Nutrien to sector perform, citing a 14% price rise and valuation concerns.

Expected impact

Modest decline expected if investors follow the downgrade.

Evidence & confidence

Downgrade reflects valuation stretch; target raised but rating lowered, indicating risk of pullback.

$CVEBullishMedium confidence
Context

TD Cowen reaffirmed an outperform rating and $60 price target for Cenovus, highlighting strong upstream momentum and discount to peers.

Expected impact

Potential modest rally if market digests the upbeat outlook.

Evidence & confidence

Analyst emphasizes strong cash flow and discount valuation, which could attract buyers.

$HITIBullishLow confidence
Context

Derek Lessard of TD Cowen highlighted meaningful incremental value in High Tide Inc., noting strong execution and Q3 guidance beat.

Expected impact

Possible short-term bounce if investors act on the positive commentary.

Evidence & confidence

While commentary is favorable, the stock's large decline limits immediate upside.

Market effects

Fertilizer and oil‑sand sectors see mixed sentiment due to valuation concerns and upbeat upstream outlook.

Canadian equities may experience modest volatility from the rating changes.

Limited; impacts primarily North American commodity‑related stocks.

Counterpoint

Investors could view the downgrades as buying opportunities given the underlying fundamentals remain strong.

Key entities

  • National Bank Financial

    Provided downgrade for Nutrien.

  • TD Cowen

    Reaffirmed rating for Cenovus and commented on High Tide.

Related articles

$HITIMed

High Tide Q3 Earnings Call Highlights

High Tide reported Q3 earnings with CAD 7M in free cash flow, up 44% YoY. The company operates 232 Canna Cabana stores in Canada, with plans to add 20 more in 2026. Its German medical cannabis business, Remexian, saw a 35% sequential increase in sales. Management highlighted strong market share and growth in key regions, despite some operational challenges.

$HITIMed

High Tide Inc. (HITI): Financial results for Q3 2026

High Tide Inc. (HITI) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 High Tide Reports Record-Breaking Third Quarter 2026 Financial Results High Tide Inc., September 14, 2026 • RECORD Quarterly Revenue of $199 Million and Annualized Revenue Run Rate of Approximately $800 Million • RECORD Gross Profit of $52.7 Million • RECORD Adjusted

$NTRMedAI 8/10

Nutrien Gains 17% in the Past Month: What's Driving the Stock?

Nutrien Ltd.'s shares have risen 17.2% in the past month, outperforming the Zacks Fertilizers industry. The company reported strong fertilizer market fundamentals, higher potash and nitrogen prices, and improved cost efficiency. Nutrien raised its potash sales guidance to 14.2-14.8 million tons for the year, with record first-half sales of 7.45 million tons. The company also expects sustained demand for nitrogen and proprietary product growth, with adjusted EBITDA guidance of $1.75-$1.95 billion

$NTRMed

Why You Should Retain Nutrien Stock in Your Portfolio Now

Nutrien Ltd. (NTR) reports record potash volumes and higher fertilizer prices, driving a 36.8% stock gain over a year. The company benefits from strong nitrogen fundamentals and proprietary product growth, but faces challenges from elevated sulfur costs and constrained nitrogen volumes. Management raised potash sales guidance and lowered capital expenditure forecasts. NTR's Retail business sees higher margins, but weaker crop nutrient volumes limit earnings growth. The stock is rated 'Hold' by Z